Brian Guan-Chyun Liu, a director at $CGON, bought 1,515,151 shares of the company on 09-11-2025 for an estimated $49,999,983. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings of this class of stock by approximately inf%. Following this trade, they now own 1,515,151 shares of this class of $CGON stock.
$CGON Insider Trading Activity
$CGON insiders have traded $CGON stock on the open market 14 times in the past 6 months. Of those trades, 1 have been purchases and 13 have been sales.
Here’s a breakdown of recent trading of $CGON stock by insiders over the last 6 months:
- BRIAN GUAN-CHYUN LIU purchased 1,515,151 shares for an estimated $49,999,983
- HONG FANG SONG has made 0 purchases and 4 sales selling 100,000 shares for an estimated $2,779,542.
- JAMES MULAY has made 0 purchases and 4 sales selling 27,015 shares for an estimated $851,797.
- LEONARD E POST has made 0 purchases and 5 sales selling 6,000 shares for an estimated $170,760.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CGON Hedge Fund Activity
We have seen 115 institutional investors add shares of $CGON stock to their portfolio, and 67 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MARSHALL WACE, LLP removed 2,418,456 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $62,879,856
- BANK OF AMERICA CORP /DE/ added 1,396,170 shares (+409.9%) to their portfolio in Q2 2025, for an estimated $36,300,420
- FMR LLC added 1,311,163 shares (+51.5%) to their portfolio in Q2 2025, for an estimated $34,090,238
- JANUS HENDERSON GROUP PLC removed 1,259,241 shares (-98.6%) from their portfolio in Q2 2025, for an estimated $32,740,266
- PRICE T ROWE ASSOCIATES INC /MD/ added 999,094 shares (+98.5%) to their portfolio in Q2 2025, for an estimated $25,976,444
- CITADEL ADVISORS LLC removed 963,665 shares (-84.6%) from their portfolio in Q2 2025, for an estimated $25,055,290
- MORGAN STANLEY added 923,067 shares (+97.7%) to their portfolio in Q2 2025, for an estimated $23,999,742
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CGON Analyst Ratings
Wall Street analysts have issued reports on $CGON in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HC Wainwright & Co. issued a "Buy" rating on 09/15/2025
- Cantor Fitzgerald issued a "Overweight" rating on 09/08/2025
- Jones Trading issued a "Buy" rating on 09/08/2025
- Piper Sandler issued a "Overweight" rating on 08/19/2025
- RBC Capital issued a "Outperform" rating on 07/16/2025
- Morgan Stanley issued a "Overweight" rating on 06/17/2025
- JP Morgan issued a "Overweight" rating on 05/02/2025
To track analyst ratings and price targets for $CGON, check out Quiver Quantitative's $CGON forecast page.
$CGON Price Targets
Multiple analysts have issued price targets for $CGON recently. We have seen 10 analysts offer price targets for $CGON in the last 6 months, with a median target of $55.5.
Here are some recent targets:
- Andres Y. Maldonado from HC Wainwright & Co. set a target price of $75.0 on 09/15/2025
- Soumit Roy from Jones Trading set a target price of $50.0 on 09/08/2025
- Josh Schimmer from Cantor Fitzgerald set a target price of $75.0 on 09/08/2025
- Kelsey Goodwin from Piper Sandler set a target price of $55.0 on 08/19/2025
- Leonid Timashev from RBC Capital set a target price of $53.0 on 07/16/2025
- Jeffrey Hung from Morgan Stanley set a target price of $56.0 on 06/17/2025
- Brian Cheng from JP Morgan set a target price of $41.0 on 05/02/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
